You are here

Article Text

Article menu
Download PDFPDF
Editorial commentary
Food of the gods for the treatment of multiple sclerosis related fatigue?
  1. Paolo Ragonese
  1. Department of Experimental, Biomedicine and Clinical Neurosciences, University of Palermo, Palermo 90129, Italy
  1. Correspondence to Dr Paolo Ragonese, Department of Experimental, Biomedicine and Clinical Neurosciences, University of Palermo, Palermo 90129, Italy; paolo.ragonese{at}unipa.it

https://doi.org/10.1136/jnnp-2018-319926

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Preliminary results from a feasibility study suggest a potential role for flavonoid enriched cocoa to treat fatigue, one of the most challenging symptoms of multiple sclerosis

    In their JNNP paper, Coe et al report the preliminary results of a feasibility trial on flavonoid enriched cocoa for the treatment of multiple sclerosis (MS) related fatigue, showing promising results that encourage the conduction of a phase III clinical trial to confirm the results of possible clinical effects on MS related fatigue.1

    As described in the paper,1 fatigue is the most common symptom reported by individuals affected by MS, affecting the majority of patients. It is often present even when neurological disability is low and in the early stages of the disease, but impacts significantly the quality of life in MS patients, diminishing independence in everyday activities. Fatigue symptoms are described by patients as tiredness, generalised …

    View Full Text

    Footnotes

    • Contributors I am the only author of the manuscript since it is an invited editorial commentary.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent Not required.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles